Diabetes Devices Market Size, Share, Growth, and Industry Analysis, By Type (Blood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices), By Application (Hospital, Personal Use, Clinic, Others), and Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

DIABETES DEVICES MARKET OVERVIEW

The global Diabetes Devices Market size was USD 25.40 billion in 2026 and is projected to touch USD 44.00 billion by 2035, exhibiting a CAGR of 6.3% during the forecast period.

The global demand for diabetes care and monitoring devices is the main driver of the strong growth of the Diabetes Devices Market. These changes in lifestyle, aging populations, and increasing obesity rates are some of the factors that have led to an increase in the number of people suffering from diabetes worldwide. Patients’ demand for continuous and reliable glucose monitoring as well as for insulin delivery is pushing the market to offer more and more sophisticated, yet user-friendly devices. Among the innovations that are transforming patient care are CGM, smart insulin pumps, connected meters, and digital diabetes management platforms which provide real-time insights, better glycemic control, and lower dependence on conventional methods. The combination of mobile apps, cloud analytics, and AI-assisted data interpretation is making disease management more effective, thus allowing patients and healthcare professionals to make better-informed decisions.

Another thing that can be noticed in the market is a quick change from finger-sticks testing methods to the ones that are less invasions and more automated testing solution. Device makers are now producing smaller, wearable and interoperable devices, which not only solve the problem of patient's discomfort but also make patient adherence, and long-term outcomes better. Additionally, market growth is supported by continuous efforts from government and health organizations in the form of awareness creation, access improvement in less developed areas of the world, and health initiatives. On the other hand, competition caused by different levels of reimbursement given to various health insurances and limited accessibility due to urban-rural divide in low-income countries continue to influence the adoption of such devices. Still, the technology barrier that has been broken through and the personalized digital health system that has been created, both still serve as catalysts for the market.

COVID-19 IMPACT

Diabetes Devices Industry Had a Positive Effect Due to Surge in Demand during the COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The pandemic had a huge impact on the home glucose monitoring market as patients shunned hospitals and clinics due to the risk of getting infected. This encouraged the use of CGMs, smart glucose meters, and remote insulin delivery systems. A lot of patients moved from manual testing to connected devices, as the latter provided real-time data and reduced the need for frequent checkups. The lockdowns acted as a catalyst for telemedicine adoption and digital diabetes management for both doctors and patients.

The pandemic caused global manufacturing and logistics to overturn drastically, causing a shortage of sensors, test strips, insulin pumps, and glucose meters. The unavailability of components and raw materials increased production lead times, and consequently, limited the market growth in the early COVID-19 phase. Also, during the tightest lockdowns, lots of people did not go for routine checkups, screenings, and diabetes assessments.

LATEST TRENDS

Automated Insulin Delivery (AID) Systems to Drive Market Growth

Automated Insulin Delivery (AID) Systems are vital benefits of diabetes devices market share. The rapid development and adoption of Automated Insulin Delivery (AID) systems is the leading trend in insulin delivery technology, which is often referred to as hybrid closed-loop or "artificial pancreas" technology. A CGM device, an insulin pump (which is commonly a discrete, tubeless patch pump), and an advanced dosing algorithm (powered by AI/ML) that continuously modifies basal insulin delivery and gives micro-correction boluses according to current and predicted glucose trends are the three basic components of these systems. Manufacturers are aggressively working on systems that demand minimal user interaction, thus making the daily management very easy for the Type 1 diabetes patients.

•   
•   
  

  Download Free Sample to learn more about this report

    

DIABETES DEVICES MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Blood Glucose Monitoring (BGM) Devices, Insulin Delivery Devices.

• Blood Glucose Monitoring (BGM) Devices: Blood Glucose Monitoring devices help patients measure glucose levels through test strips, meters, or minimally invasive sensors, offering quick and accurate readings. They support daily diabetes management by enabling timely adjustments to diet, medication, and insulin use.

• Insulin Delivery Devices: Insulin delivery devices—such as insulin pens, pumps, and smart injectors—provide controlled and precise insulin dosing to maintain stable blood glucose levels. These technologies improve convenience, reduce injection errors, and support better long-term glycemic control.

By Application

Based on application, the global market can be categorized into Hospital, Personal Use, Clinic, Others.

• Hospital: Hospitals use advanced diabetes devices for continuous monitoring and rapid insulin administration in critical or acute care settings. These devices support accurate diagnosis, treatment adjustment, and real-time supervision of complex diabetes cases.

• Personal Use: Personal-use diabetes devices enable patients to monitor and manage their condition independently at home. They emphasize convenience, ease of use, and connectivity to support daily glucose tracking and insulin delivery.

• Clinic: Clinics utilize diabetes devices for routine checkups, monitoring trends, and adjusting long-term treatment plans. They rely on accurate readings and data-backed insights to guide personalized care for both newly diagnosed and existing patients.

• Others: The “Others” segment includes long-term care centers, ambulatory care units, pharmacies, and community health programs that use diabetes devices for screening and ongoing management. These settings help expand accessibility and support broader diabetes awareness and care initiatives.

MARKET DYNAMICS

Driving Factors

Global Prevalence of Diabetes to Boost the Market

A factor in the diabetes devices market growth is global prevalence of diabetes. The global surge in diabetes Type 1 and 2 cases is driving the need for monitoring and insulin delivery devices to be persistent. The rise is also being taken up by changes in lifestyle, obesity, and lack of physical activity. Officially, there are alarming figures reported for both cases diagnosed and those not diagnosed yet by governments and health organizations. It is an undeniable fact that diabetes has turned into a long-term disease requiring management, thus making the regular use of devices necessary instead of just preferred. The market's growth is directly supported by this ever-increasing demand. Patients' adoption of devices will be directly proportional to the rise in prevalence.

Technological Advancements to Expand the Market

Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring (FGM) systems are gaining in accuracy, ease of use, and connectivity. The integration of smartphones, the sharing of data via the cloud, and the alerts based on predictions are the features that are putting both patients and clinicians under the spell. The significant improvement in sensors and miniaturization has led to devices that are less painful and more convenient to use. The monitoring that is done in real-time not only decreases the chances of hypoglycemia but also leads to the adoption of more proactive management. These innovations have a remarkable impact on the increase of the adoption rates and customer satisfaction. The importance of early diagnosis and frequent monitoring is being emphasized through awareness campaigns run by governments and non-governmental organizations (NGOs).

Restraining Factor

Reimbursement Limitations and High Cost to Potentially Impede Market Growth

In contrast to the U.S. or EU, reimbursement for diabetes devices is either eliminated or very limited to developing countries. Patients have to pay full costs, which makes it impossible for them to use advanced technologies. Insulin pumps and CGMs are still considered to be luxury items. On the other hand, the insurance issue further raises the cost of these devices thus, the patients would rather not use them at all. Such a situation that is in favor of the slow growth of the emerging markets is created by the disparity. CGMs, insulin pumps, and smart pens come with very high initial and maintenance costs. The majority of patients in developing countries are unable to buy these technologies. On top of that, the replacement of sensors and supplies entails additional costs which are recurring.

Growth of AI-Powered and Predictive Analytics Tools To Create Opportunity for the Product in the Market

Opportunity

The incorporation of AI can improve the monitoring in real-time, insulin dosing automation, and glucose level fluctuations prediction. The use of smart algorithms can benefit the patients and make the devices more proactive. The companies that will accept AI-based innovations will be the ones who will have the best market position.

The providers of healthcare are fond of advanced analytics for their decision-making process. This creates a lot of opportunities for the new diabetes management systems. The countries like India, China, Brazil, and Indonesia have the highest number of new diabetes patients due to their rapidly increasing diabetic populations. Urbanization and the changing eating habits are the factors that are causing the incidence rates to go higher.

Intense Competition Could Be a Potential Challenge for Consumers

Challenge

The market for diabetes devices is overrun by various international companies providing almost identical technologies. The competition has an impact on the prices, and thus, the profitability is minimized. The little players have a hard time against the giants, keeping the market very difficult. The only way to maintain market presence is through continuous innovation.

This cutthroat competition makes the business atmosphere very challenging. It is very hard to produce attest that is consistent over different conditions and among various users. The use of sensor technology has to be extremely dependable, or else mismanagement might occur. Inaccuracy can cause very serious health problems; hence, precision becomes very important.

•   
•   
  Download Free Sample to learn more about this report

    

DIABETES DEVICES MARKET REGIONAL INSIGHTS

• North America

North America is the fastest-growing region in this market. The United States diabetes devices market has been growing exponentially for multiple reasons. North America is the most mature market for diabetes devices and also the most innovative one. The major reasons for this are the prevalence of the disease, good coverage by payers, and the adoption of advanced technologies, such as CGMs, smart insulin pumps, and integrated digital platforms in a large scale. The early adoption of these technologies is primarily done by hospitals, large clinics, and specialized diabetes centers, while a strong aftermarket and well-established home care ecosystem continue to support the frequent replacement of sensors and consumables. Reimbursement schemes (private insurance and Medicare/Medicaid) significantly lower the out-of-pocket costs for patients with premium devices in many segments, which in turn accelerates the uptake of closed-loop and remote-monitoring solutions.

• Europe

Europe amalgamates top-notch clinical standards along with slow, regulation-led adoption and strong public health programs aimed at prevention and chronic disease management, thus, hospitals, primary care networks, and national screening initiatives would find a constant demand for diabetes devices. The reimbursement system is different in each country, thus the manufacturers have to devise a pricing and market-access strategy suited to each country—CGMs and pumps are generally reimbursed broadly in the Nordic and Western European markets, whereas some Southern and Eastern markets are still struggling with this issue, hence the regional inconsistency is created. The European buyers give a lot of weight to the factors that make the device safe, its cost-effectiveness in the long run, the sustainability of the consumables, and data privacy (GDPR), hence, the suppliers that provide secure, evidence-backed solutions and local data residency options are the ones that will benefit from the situation.

• Asia

Asia-Pacific region is the one which has the quickest growth and the most variety, and this is mainly due to the very high increase in diabetes cases, the rising middle class, and the faster adoption of digital health—however, it is still very different from country to country in terms of access, reimbursement, and clinical practice. Japan, South Korea, China, and Australia are the leaders in the market and they have the strongest adoption of advanced CGMs, pumps, and integrated management systems; China and India in particular are huge opportunities in terms of volume because they have scale, increasing private healthcare spending, and local manufacturing partnerships. The sensitivity to prices and the large differences in payer coverage are factors that lead vendors to offer tiered portfolios as the most common practice—selling the premium connected devices in rich urban areas and providing the low-priced meters and strips in wide rural areas.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

The Diabetes Devices Market is transformed by the major players of the industry who depend on continual technological alterations and strategic expansion. The companies are combining the latest manufacturing methods while also creating the future generations of monitoring as well as insulin delivery solutions aimed at making the whole process more precise, comfortable, and usable for patients. They are also expanding their product lines with specialized items such as wearable CGMs, automatic insulin pumps, smart pens, and digital platforms that are connected to cater to the various needs of people from different age groups and diabetes states. Moreover, the top manufacturers are taking advantage of the digital ecosystems to not only enhance their market size but also to make their sales processes more efficient and distribution routes less costly, thus providing better access to diabetes devices particularly in areas where there is an increase in the number of people afflicted with diabetes.

List Of Top Diabetes Devices Companies

• Medtronic (U.S.)
• Sanofi (France)
• Bayer (Germany)
• Becton, Dickinson and Company (U.S.)
• Novo Nordisk (Denmark)
• Abbott Laboratories (U.S.)

KEY INDUSTRY DEVELOPMENT

November 2025: Dexcom received FDA clearance for Smart Basal, a major software innovation that integrates with its G7 15-day sensor. Smart Basal is the first and only CGM-integrated basal insulin dosing optimizer for adults with Type 2 diabetes on glargine U-100 long-acting insulin therapy.

REPORT COVERAGE

The study offers a detailed SWOT analysis and provides valuable insights into future developments within the market. It explores various factors driving market growth, examining a broad range of market segments and potential applications that may shape its trajectory in the coming years. The analysis considers both current trends and historical milestones to provide a comprehensive understanding of the market dynamics, highlighting potential growth areas.

The diabetes devices market is poised for significant growth, driven by evolving consumer preferences, rising demand across various applications, and ongoing innovation in product offerings. Although challenges such as limited raw material availability and higher costs may arise, the market's expansion is supported by increasing interest in specialized solutions and quality improvements. Key industry players are advancing through technological advancements and strategic expansions, enhancing both supply and market reach. As market dynamics shift and demand for diverse options increases, the diabetes devices market is expected to thrive, with continuous innovation and broader adoption fueling its future trajectory.